364 related articles for article (PubMed ID: 28323825)
1. Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study.
Snowden SG; Ebshiana AA; Hye A; An Y; Pletnikova O; O'Brien R; Troncoso J; Legido-Quigley C; Thambisetty M
PLoS Med; 2017 Mar; 14(3):e1002266. PubMed ID: 28323825
[TBL] [Abstract][Full Text] [Related]
2. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
Mahajan UV; Varma VR; Griswold ME; Blackshear CT; An Y; Oommen AM; Varma S; Troncoso JC; Pletnikova O; O'Brien R; Hohman TJ; Legido-Quigley C; Thambisetty M
PLoS Med; 2020 Jan; 17(1):e1003012. PubMed ID: 31978055
[TBL] [Abstract][Full Text] [Related]
4. Neurotransmitter Imbalance in the Brain and Alzheimer's Disease Pathology.
Snowden SG; Ebshiana AA; Hye A; Pletnikova O; O'Brien R; Yang A; Troncoso J; Legido-Quigley C; Thambisetty M
J Alzheimers Dis; 2019; 72(1):35-43. PubMed ID: 31561368
[TBL] [Abstract][Full Text] [Related]
5. Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent β-amyloid and tau loads with divergent cognitive outcomes.
Iacono D; Resnick SM; O'Brien R; Zonderman AB; An Y; Pletnikova O; Rudow G; Crain B; Troncoso JC
J Neuropathol Exp Neurol; 2014 Apr; 73(4):295-304. PubMed ID: 24607960
[TBL] [Abstract][Full Text] [Related]
6. Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease.
Cunnane SC; Schneider JA; Tangney C; Tremblay-Mercier J; Fortier M; Bennett DA; Morris MC
J Alzheimers Dis; 2012; 29(3):691-7. PubMed ID: 22466064
[TBL] [Abstract][Full Text] [Related]
7. Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study.
Millar PR; Gordon BA; Luckett PH; Benzinger TLS; Cruchaga C; Fagan AM; Hassenstab JJ; Perrin RJ; Schindler SE; Allegri RF; Day GS; Farlow MR; Mori H; Nübling G; ; Bateman RJ; Morris JC; Ances BM
Elife; 2023 Jan; 12():. PubMed ID: 36607335
[TBL] [Abstract][Full Text] [Related]
8. Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder.
Xu J; Begley P; Church SJ; Patassini S; Hollywood KA; Jüllig M; Curtis MA; Waldvogel HJ; Faull RL; Unwin RD; Cooper GJ
Biochim Biophys Acta; 2016 Jun; 1862(6):1084-92. PubMed ID: 26957286
[TBL] [Abstract][Full Text] [Related]
9. Peripheral serum metabolomic profiles inform central cognitive impairment.
Wang J; Wei R; Xie G; Arnold M; Kueider-Paisley A; Louie G; Mahmoudian Dehkordi S; Blach C; Baillie R; Han X; De Jager PL; Bennett DA; Kaddurah-Daouk R; Jia W
Sci Rep; 2020 Aug; 10(1):14059. PubMed ID: 32820198
[TBL] [Abstract][Full Text] [Related]
10. Eicosapentaenoic Acid Is Associated with Decreased Incidence of Alzheimer's Dementia in the Oldest Old.
Melo van Lent D; Egert S; Wolfsgruber S; Kleineidam L; Weinhold L; Wagner-Thelen H; Maier W; Jessen F; Ramirez A; Schmid M; Scherer M; Riedel-Heller SG; Wagner M
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33573174
[TBL] [Abstract][Full Text] [Related]
11. Bile acid synthesis, modulation, and dementia: A metabolomic, transcriptomic, and pharmacoepidemiologic study.
Varma VR; Wang Y; An Y; Varma S; Bilgel M; Doshi J; Legido-Quigley C; Delgado JC; Oommen AM; Roberts JA; Wong DF; Davatzikos C; Resnick SM; Troncoso JC; Pletnikova O; O'Brien R; Hak E; Baak BN; Pfeiffer R; Baloni P; Mohmoudiandehkordi S; Nho K; Kaddurah-Daouk R; Bennett DA; Gadalla SM; Thambisetty M
PLoS Med; 2021 May; 18(5):e1003615. PubMed ID: 34043628
[TBL] [Abstract][Full Text] [Related]
12. Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly.
Driscoll I; Resnick SM; Troncoso JC; An Y; O'Brien R; Zonderman AB
Ann Neurol; 2006 Dec; 60(6):688-95. PubMed ID: 17192929
[TBL] [Abstract][Full Text] [Related]
13. Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation.
Chuang YF; An Y; Bilgel M; Wong DF; Troncoso JC; O'Brien RJ; Breitner JC; Ferruci L; Resnick SM; Thambisetty M
Mol Psychiatry; 2016 Jul; 21(7):910-5. PubMed ID: 26324099
[TBL] [Abstract][Full Text] [Related]
14. Sex-Specific Association of the X Chromosome With Cognitive Change and Tau Pathology in Aging and Alzheimer Disease.
Davis EJ; Solsberg CW; White CC; Miñones-Moyano E; Sirota M; Chibnik L; Bennett DA; De Jager PL; Yokoyama JS; Dubal DB
JAMA Neurol; 2021 Oct; 78(10):1249-1254. PubMed ID: 34424272
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of functional compensation, delineated by eigenvector centrality mapping, across the pathophysiological continuum of Alzheimer's disease.
Skouras S; Falcon C; Tucholka A; Rami L; Sanchez-Valle R; Lladó A; Gispert JD; Molinuevo JL
Neuroimage Clin; 2019; 22():101777. PubMed ID: 30913531
[TBL] [Abstract][Full Text] [Related]
16. Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis.
Huo Z; Yu L; Yang J; Zhu Y; Bennett DA; Zhao J
Neurobiol Aging; 2020 Feb; 86():123-133. PubMed ID: 31785839
[TBL] [Abstract][Full Text] [Related]
17. Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging.
Thambisetty M; Jeffrey Metter E; Yang A; Dolan H; Marano C; Zonderman AB; Troncoso JC; Zhou Y; Wong DF; Ferrucci L; Egan J; Resnick SM; O'Brien RJ
JAMA Neurol; 2013 Sep; 70(9):1167-72. PubMed ID: 23897112
[TBL] [Abstract][Full Text] [Related]
18. Rat Hair Metabolomics Analysis Reveals Perturbations of Unsaturated Fatty Acid Biosynthesis, Phenylalanine, and Arachidonic Acid Metabolism Pathways Are Associated with Amyloid-β-Induced Cognitive Deficits.
Tan TH; Li SW; Chang CW; Chen YC; Liu YH; Ma JT; Chang CP; Liao PC
Mol Neurobiol; 2023 Aug; 60(8):4373-4395. PubMed ID: 37095368
[TBL] [Abstract][Full Text] [Related]
19. Integration of Multilocus Genetic Risk into the Default Mode Network Longitudinal Trajectory during the Alzheimer's Disease Process.
Su F; Shu H; Ye Q; Xie C; Yuan B; Zhang Z; Bai F
J Alzheimers Dis; 2017; 56(2):491-507. PubMed ID: 28035927
[TBL] [Abstract][Full Text] [Related]
20. Regional membrane phospholipid alterations in Alzheimer's disease.
Prasad MR; Lovell MA; Yatin M; Dhillon H; Markesbery WR
Neurochem Res; 1998 Jan; 23(1):81-8. PubMed ID: 9482271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
